NavacimTD

N/A

Report date: 2025/03/20 16:04:18

Base Information

Drug NameNavacimTD
Drug Alias Namenanoparticle vaccine (Parvus Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Calgary
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag
Inactive CompaniesParvus Therapeutics Inc
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A